Gilbert & Cook, Inc. Gilead Sciences, Inc. Transaction History

Gilbert & Cook, Inc.

$718 Million
Q3 2024

A detailed history of Gilbert & Cook, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Gilbert & Cook, Inc. holds 3,260 shares of GILD stock, worth $293,008. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,260

Previous 3,264 0.12%

Holding current value

$293,008

Previous $223,000 22.42%

% of portfolio

0.04%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$66.59 - $83.99 $266 - $335	-4 Reduced 0.12%	3,260 $273,000
Q2 2024 Aug 01, 2024	SELL	$63.15 - $72.88 $18,124 - $20,916	-287 Reduced 8.08%	3,264 $223,000
Q1 2024 May 02, 2024	SELL	$71.58 - $87.29 $231,919 - $282,819	-3,240 Reduced 47.71%	3,551 $260,000
Q4 2023 Feb 05, 2024	BUY	$73.27 - $83.09 $25,204 - $28,582	344 Added 5.34%	6,791 $550,000
Q3 2023 Nov 02, 2023	BUY	$73.94 - $80.67 $45,547 - $49,692	616 Added 10.56%	6,447 $483,000
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $23,715 - $27,050	312 Added 5.65%	5,831 $449,000
Q1 2023 May 05, 2023	BUY	$77.31 - $88.08 $4,793 - $5,460	62 Added 1.14%	5,519 $457,000
Q4 2022 Feb 09, 2023	BUY	$62.32 - $89.47 $5,608 - $8,052	90 Added 1.68%	5,457 $468,000
Q3 2022 Nov 03, 2022	BUY	$59.54 - $68.01 $5,537 - $6,324	93 Added 1.76%	5,367 $418,000
Q2 2022 Aug 05, 2022	BUY	$57.72 - $65.01 $5,541 - $6,240	96 Added 1.85%	5,274 $326,000
Q1 2022 May 02, 2022	BUY	$57.92 - $72.58 $16,449 - $20,612	284 Added 5.8%	5,178 $308,000
Q4 2021 Jan 19, 2022	BUY	$64.88 - $73.64 $11,159 - $12,666	172 Added 3.64%	4,894 $355,000
Q3 2021 Jan 20, 2022	BUY	$67.69 - $73.03 $2,030 - $2,190	30 Added 0.64%	4,722 $330,000
Q3 2021 Oct 13, 2021	BUY	$67.69 - $73.03 $12,387 - $13,364	183 Added 4.06%	4,692 $330,000
Q2 2021 Jul 13, 2021	BUY	$63.47 - $69.35 $6,981 - $7,628	110 Added 2.5%	4,509 $310,000
Q1 2021 Apr 14, 2021	BUY	$60.0 - $68.46 $26,760 - $30,533	446 Added 11.28%	4,399 $284,000
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $32,630 - $37,180	576 Added 17.06%	3,953 $231,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $19,623 - $24,673	316 Added 10.32%	3,377 $213,000
Q2 2020 Aug 05, 2020	BUY	$72.34 - $84.0 $20,689 - $24,024	286 Added 10.31%	3,061 $236,000
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $173,798 - $222,610	2,775 New	2,775 $207,000
Q1 2018 Apr 30, 2018	SELL	$72.84 - $88.8 $257,707 - $314,174	-3,538 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$71.15 - $83.52 $29,883 - $35,078	420 Added 13.47%	3,538 $253,000
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $224,838 - $266,495	3,118	3,118 $253,000

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilbert & Cook, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gilbert & Cook, Inc. with notifications on news.

Account